Articles, updates, and perspectives on fertility innovation.
Fecundis Receives CDTI Multi-país Funding for Spermy
Fecundis Lab has received CDTI Multi-país funding for Spermy, an international R&D project to develop an artificial intelligence platform for semen analysis in assisted reproduction.
Fecundis at ESHRE 2026: Bringing Sperm Biology Into the IVF Conversation
Fecundis joined ESHRE 2026 in London, presenting HyperSperm and discussing the growing role of sperm biology, capacitation, and functional sperm preparation in the future of IVF.
Biology-Inspired Sperm Selection: Can It Improve Embryo Quality in ICSI?
A new ICSI study suggests that cumulus cell-mediated sperm selection may improve blastocyst rates, highlighting the importance of sperm physiology beyond motility and morphology.
New Clinical Evidence Shows HyperSperm™ Improves Blastocyst Yield and Embryo Quality in IVF
A new multicenter clinical study published in Journal of Translational Medicine shows that HyperSperm improves blastocyst yield and embryo quality in IVF patients.
Fecundis Lab has received Eurostars funding for HyperFlow, an international R&D project to develop an automated microfluidic device for sperm selection and functional enhancement in IVF.
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking “Accept All”, you consent to our use of cookies.
You can change or withdraw your consent at any time using the privacy settings button.
